Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721, USA.
Environ Mol Mutagen. 2012 Jan;53(1):32-43. doi: 10.1002/em.21674. Epub 2011 Dec 15.
The tumor suppressor breast cancer susceptibility protein 1 (BRCA1) protects our cells from genomic instability in part by facilitating the efficient repair of DNA double-strand breaks (DSBs). BRCA1 promotes the error-free repair of DSBs through homologous recombination and is also implicated in the regulation of nonhomologous end joining (NHEJ) repair fidelity. Here, we investigate the role of BRCA1 in NHEJ repair mutagenesis following a DSB. We examined the frequency of microhomology-mediated end joining (MMEJ) and the fidelity of DSB repair relative to BRCA1 protein levels in both control and tumorigenic breast epithelial cells. In addition to altered BRCA1 protein levels, we tested the effects of cellular exposure to mirin, an inhibitor of meiotic recombination enzyme 11 (Mre11) 3'-5'-exonuclease activity. Knockdown or loss of BRCA1 protein resulted in an increased frequency of overall plasmid DNA mutagenesis and MMEJ following a DSB. Inhibition of Mre11-exonuclease activity with mirin significantly decreased the occurrence of MMEJ, but did not considerably affect the overall mutagenic frequency of plasmid DSB repair. The results suggest that BRCA1 protects DNA from mutagenesis during nonhomologous DSB repair in plasmid-based assays. The increased frequency of DSB mutagenesis and MMEJ repair in the absence of BRCA1 suggests a potential mechanism for carcinogenesis.
肿瘤抑制因子乳腺癌易感蛋白 1(BRCA1)通过促进 DNA 双链断裂(DSB)的有效修复,在一定程度上保护我们的细胞免受基因组不稳定性的影响。BRCA1 通过同源重组促进 DSB 的无差错修复,并且还与非同源末端连接(NHEJ)修复保真度的调节有关。在这里,我们研究了 BRCA1 在 DSB 后 NHEJ 修复突变中的作用。我们检查了微同源介导的末端连接(MMEJ)的频率以及相对于 BRCA1 蛋白水平的 DSB 修复的保真度,分别在对照和致瘤性乳腺上皮细胞中进行。除了改变 BRCA1 蛋白水平外,我们还测试了细胞暴露于 mirin 的影响,mirin 是一种抑制减数分裂重组酶 11(Mre11)3'-5'-核酸外切酶活性的抑制剂。BRCA1 蛋白的敲低或缺失导致质粒 DNA 突变和 DSB 后 MMEJ 的频率增加。用 mirin 抑制 Mre11-核酸外切酶活性显著降低了 MMEJ 的发生,但对质粒 DSB 修复的总体突变频率没有显著影响。结果表明,BRCA1 在基于质粒的测定中保护 DNA 免受非同源 DSB 修复过程中的突变。在没有 BRCA1 的情况下,DSB 突变和 MMEJ 修复的频率增加表明了致癌作用的潜在机制。